Quantum BioPharma receives $2.35M from settlement with Raza Bokhari

Quantum BioPharma announced that the Company and Dr. Raza Bokhari, Company’s former Executive Chairman and CEO, have reached a global settlement agreement to settle all and any disputes originating out of the proxy contest originally commencing January 2021. Zeeshan Saeed, Co-Chairman & CEO, and Anthony Durkacz, Co-Chairman of the Company, also signed the agreement in their personal capacity. The agreement brings to a complete and final closure all outstanding issues and prevents any future litigation in various courts in Canada and the United States. The payment of $2,350,000 from Dr. Bokhari to Quantum BioPharma satisfies all outstanding monetary claims by the Company, Zeeshan Saeed, Anthony Durkacz and other current or former employees, officers, Directors, affiliates or agents of the Company as well as any and all legal and monetary claims by Dr. Bokhari. The $2,350,000 is a non-dilutive injection of cash into Quantum BioPharma. In the agreement, Dr. Raza Bokhari, Quantum BioPharma, Zeeshan Saeed and Anthony Durkacz did not admit to any wrongdoing. All parties agreed that at all times they were acting in the best interest of the corporation and the shareholders.